On January 15, 2008, DTS Language Services, Inc. is inviting the attendance and participation of biotech,
pharmaceutical, and life sciences members to discuss how to avoid problems in reaching international
audiences at its Open House. The event will run from 11:00 AM until 7:00 PM and will include informal
roundtable discussions, networking sessions, and industry-specific booklets and materials for all
In an era of dwindling drug pipelines, the search for patient naïve populations has turned to foreign
audiences on an unprecedented scale. This has often lead to document translation snafus, ranging from
the humorous to the deadly serious.
“For many U.S.-based drug companies, English is still regarded as the ‘universal language’,” Duncan
Shaw, President of DTS, Inc., said. “However, there are over 6,000 known languages worldwide,” Shaw
continued, “A non-English speaker won’t care about 5,999 of them—only theirs.”
Moreover, legal considerations require that documents such as clinical protocols, informed consent forms,
patient recruiting materials, HIPAA forms, Investigator Brochures and others must be translated into the
native language of the participating subjects. Here is where the problems begin, because of widespread
misunderstanding to questions such as:
• Can new machine-translation technology or software be used to translate documents?
• Are there generally accepted standards to determine the basis of a qualified translator?
• What protection measures can an organization take to ensure a validated translation process?
Despite spending millions of dollars in the drug development cycle, the quality-control and legal approval
of clinical trials documentation remains at risk if translations are inaccurate, ineffective or unusable.
“Life sciences are solely reliant on who they happen to know and trust. The need for education about
how to reach foreign audiences effectively has never been higher,” Shaw said.
If you’d like more information about this event, or to schedule an interview with DTS, please call
Matthew Grady at (919) 942-0666 or at email@example.com.